Financials in USD. Standardized financial statements.
A compact view of how Aadi Bioscience, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $7.14M | $25.98M | $24.35M | $15.22M | $1.12M | $14.00M | $749,000 | $20.16M | $0 | $0 |
| Revenue Growth? | -72.5% | +6.7% | +60.1% | +1258.6% | -92.0% | +1769.2% | -96.3% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $3.02M | $2.81M | $1.33M | $276,000 | $176,000 | $76,501 | $0 | $51,268 | $69,673 |
| Gross Profit? | $0 | $22.96M | $21.55M | $13.88M | -$18.55M | $13.82M | $672,499 | $20.16M | -$51,268 | -$69,673 |
| Gross Margin? | 0.0% | +88.4% | +88.5% | +91.2% | -1656.3% | +98.7% | +89.8% | +100.0% | 0.0% | 0.0% |
| Operating Expenses? | $121.55M | $90.42M | $93.48M | $72.84M | $92.67M | $16.95M | $22.50M | $31.29M | $21.34M | $16.56M |
| Operating Income? | -$114.40M | -$67.46M | -$71.93M | -$58.96M | -$111.22M | -$2.55M | -$22.58M | -$11.18M | -$21.39M | -$16.63M |
| EBITDA? | -$114.40M | -$64.63M | -$65.36M | -$60.12M | -$109.15M | -$2.48M | -$24.44M | -$10.35M | -$21.24M | -$16.43M |
| Income Before Tax | -$20.60M | -$63.69M | -$65.77M | -$60.51M | -$110.09M | -$3.48M | -$23.27M | -$10.40M | -$21.40M | -$16.98M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $2,000 | $2,000 | $1,300 | $0 | -$12,063 | -$3 |
| Net Income? | -$20.60M | -$63.69M | -$65.77M | -$60.51M | -$110.09M | -$3.48M | -$23.27M | -$10.40M | -$21.40M | -$16.98M |
| EPS? | $-0.03 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | $-26.34 | $-8.60 | $-3.30 | $-15.46 | $-11.72 |
| Diluted EPS? | $-0.03 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | $-0.51 | $-4.73 | $-2.11 | $-15.46 | $-11.72 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality